https://www.marketscreener.com/quote/stock/EXELIXIS-INC-9235/news/Exelixis-Announces-U-S-FDA-Accepts-Investigational-New-Drug-Application-for-XB002-in-Patients-wit-32885699/?utm_source=telegram&utm_medium=social&utm_campaign=share